Zhuo M, Guan Y, Yang X, Hong L, Wang Y, Li Z, Chen R, Abbas HA, Chang L, Gong Y, Wu N, Zhong J, Chen W, Chen H, Dong Z, Zhu X, Li J, Wang Y, An T, Wu M, Wang Z, Wang J, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG, Lee JJ, Heymach JV, Wistuba II, Kalhor N, Yang L, Yi X, Futreal PA, Glisson BS, Xia X, Zhang J, Zhao J. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. doi: 10.1158/1078-0432.CCR-19-0556. Epub 2019 Nov 6. PMID: 31694833; PMCID: PMC7024651.,Clin Cancer Res.,2020 Feb 15;26(4):892-901.

Yida Wang1,2#, Hanxiao Chen3#, Tianzhuo Zhang1, Xue Yang3, Jia Zhong3, Yuyan Wang3, Yujia Chi3, Meina Wu3, Tongtong An3, Jianjie Li3, Xinghui Zhao3, Zhi Dong3, Ziping Wang3, Jun Zhao*, Minglei Zhuo*, Jing Huang*,Ann Transl Med,Ann Transl Med 2021;9(1):33

Xiang Li , Shi Yan, Jichun Yang, Yaqi Wang, Chao Lv, Shaolei Li , Jun Zhao, Yue Yang, Minglei Zhuo* and Nan Wu*,Frontiers oncology,2021（10）2957

Analysis of MET kinase domain rearrangement in NSCLC Minglei Zhuoa,1, Zhen Liangb,1, Yuting Yid,1, Nan Wuc, Xue Yanga, Jia Zhonga, Xiaohan Chena, Yi Huange, Zicheng Yue, Chang Liud, Xiaoling Zengd, Wenguang Gud, Jun Zhaoa,*,LUNG CANCER,145 (2020) 140–143

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients Minglei Zhuo1?, Tongtong An1?, Chaoting Zhang2* and Ziping Wang1*,frontiers oncology,2020:10:1584.

Zhao J, Lin G, Zhuo M, Fan Z, Miao L, Chen L, Zeng A, Yin R, Ou Y, Shi Z, Yin J, Gao W, Chen J, Zhou X, Zeng Y, Liu X, Xu H, Chen R, Xia X, Carbone DP. Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.,LUNG CANCER,2020:141:114-118.

Wang Z, Duan J, Cai S, Han M, Dong H, Zhao J, Zhu B, Wang S, Zhuo M, Sun J, Wang Q, Bai H, Han J, Tian Y, Lu J, Xu T, Zhao X, Wang G, Cao X, Li F, Wang D, Chen Y, Bai Y, Zhao J, Zhao Z, Zhang Y, Xiong L, He J, Gao S, Wang J. Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.,JAMA Oncol.,2019:May 1;5(5):696-702.

Inferring the Evolution and Progression of Small- Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells Zhe Su1,2, ZhijieWang3, Xiaohui Ni1,4, Jianchun Duan3,Yan Gao1,Minglei Zhuo5, Ruoyan Li1, Jun Zhao5, Qi Ma1 , Hua Bai3, Hengyu Chen1, Shuhang Wang6, Xixi Chen1, Tongtong An5, Yuyan Wang5,Yanhua Tian2, Jiangyong Yu3, Di Wang2, Xiaoliang Sunney Xie1,4, Fan Bai1, and Jie Wang3,Clinical Cancer Research,2019;25(16):5049-5060

The adverse events associated with combination immunotherapy in cancers: Challenges and chances,Asia-Pac J Clin Oncol. 2020;1–6.,16(5):e154-e159

老年肺癌综合治疗学, 参编, 北京大学医学出版社, 2020.11

优秀援疆干部人才, 优秀援疆干部人才, 第1完成人, 新疆维吾尔自治区党委, 2020.1

肺癌内科药物治疗，包括分子靶向及免疫治疗疗效预测、耐药机制研究

非小细胞肺癌外周血免疫指标检测对于纳武单抗疗效和不良反应的预测价值分析, 课题负责人, 2020.1.1～2021.12.31, 北京大学肿瘤医院

安罗替尼对肺癌免疫微环境和外周血免疫状态的影响及其分子机制, 课题负责人, 2020.1.1～2022.12.31, 北京市医管局